Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for sedation in mechanically ventilated neurocritical care patients after head injury
PACTR202110584772902Phase 1Not yet recruiting
- Sponsor
- amr sobhy
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of dexmedetomidine in traumatic brain injury (TBI), sponsored by amr sobhy. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on PACTR202110584772902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202110584772902.